Report
Nicholas Cortellucci, CFA

BQE: Expanded Service Offering to Support Growth Strategy

What you need to know:
• BQE announced a strategic expansion of its service offering into aquatic toxicology. This includes key hiring decisions, the establishment of a new laboratory, and the development of in-house resources.
• The added services will allow BQE to build relationships with new clients, which will also require water treatment services (recurring revenue).
• BQE will be reporting Q2 financials at month end. We are expecting proportional revenue of $7.2M (+19% YoY) and adjusted EBITDA of $2.2M (30% margin, +64% YoY).

Yesterday after market close, BQE Water (BQE:TSXV, BTQNF:OTC) announced that it is making a strategic investment into the integration of aquatic toxicology services into its existing suite of core competencies. This involves key hiring decisions, the establishment of an aquatic toxicology laboratory, and the development of in-house resources. We view the announcement as a strong positive, given that it will open the doors to new clients and projects which can eventually become operations services clients. We are maintaining our BUY rating and $80.00/share target price on BQE Water.

The expansion is underpinned by a team of senior aquatic toxicologists, including James Elphick, Dr. Ebrahim (Ebi) Lari, and Josh Baker. James Elphick has spent 30 years performing applied research and testing to advance the science of aquatic toxicology and help clients gain an understanding of the causes of toxicity and the interaction of toxicants with water quality conditions.

The investment will improve BQE’s service offering by 1) reducing timelines and costs associated with implementing remedies to toxicity by having an in-house multidisciplinary team to perform all testing and design remedies, 2) consider establishment of science-based site-specific water quality benchmarks holistically, and 3) uniquely position the Company to provide guarantees to clients for effluent toxicity as part of plant operations services. The services are not only complementary to the existing technical services but also offer potential for accelerated growth in the water treatment business via new relationships. The laboratory is expected to be fully accredited, but also support the water treatment business and focus on investigative work rather than processing samples.
Underlying
BQE WATER INC.

BQE Water is engaged in the acquisition and development of processes to treat metal-laden, sulphate-rich waste water streams for acid neutralization and metal recovery. The principal operations of Co. are to build process plants and earn revenues from recovered metals, treatment fees, plant sales and process licenses.

Provider
Atrium Research Corporation
Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on North American public equities using deep fundamental analysis. Our research reports are disseminated through Bloomberg, FactSet, Capital IQ, Reuters and many more, as well as through our social media and email distribution lists. 

Analysts
Nicholas Cortellucci, CFA

Other Reports on these Companies
Other Reports from Atrium Research Corporation

ResearchPool Subscriptions

Get the most out of your insights

Get in touch